CYC116 (CYC-116)
Catalog No. A10248
CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂,Ki为8.0 nM/9.2 nM,对VEGFR2(Ki为44 nM)作用稍弱。
Catalog Num | A10248 |
---|---|
M. Wt | 368.5 |
Formula | C18H20N6OS |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 693228-63-6 |
Synonyms | CYC-116 |
SMILES | CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4 |
CYC116 (CYC-116)是一种有效的Aurora A/B抑制剂,Ki为8.0 nM/9.2 nM,对VEGFR2(Ki为44 nM)作用稍弱。
Targets
Target | Value |
---|---|
AuroraA | ki: 8nM |
AuroraB | ki: 9nM |
VEGFR2 | ki: 44nM |
FLT3 | ki: 44nM |
CDK2/CyclinE | ki: 0.39μM |
CDK9/CyclinT | ki: 0.48μM |
p70S6K | ki: 0.54μM |
Src | ki: 0.82μM |
CDK4/CyclinD | ki: 1.09μM |
LCK | ki: 2.8μM |
CDK1/CyclinB | ki: >10μM |
CDK7/CyclinH | ki: >10μM |
Abl | ki: >10μM |
Akt | ki: >10μM |
CaMKII | ki: >10μM |
CK2 | ki: >10μM |
ERK2 | ki: >10μM |
GSK-3α | ki: >10μM |
GSK-3β | ki: >10μM |
PKA | ki: >10μM |
PKC | ki: >10μM |
SAPK2A(p38α) | ki: >10μM |
PLK1 | ki: >10μM |
In vitro (25°C) | DMSO | Warmed: 24 mg/mL (65.13 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 27.14 mL | 135.69 mL | 271.37 mL |
0.5 mM | 5.43 mL | 27.14 mL | 54.27 mL |
1 mM | 2.71 mL | 13.57 mL | 27.14 mL |
5 mM | 0.54 mL | 2.71 mL | 5.43 mL |
*The above data is based on the productmolecular weight 368.5. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.